Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 1, Pages 123-130Publisher
SPRINGER
DOI: 10.1007/s00262-014-1641-9
Keywords
Adoptive immunotherapy; Genetically modified T cells; Suicide genes; NIBIT 2013
Categories
Funding
- Italian Association for Cancer Research [9965]
Ask authors/readers for more resources
The recent successes of clinical trials with T cells genetically modified with either clonal T cell receptors or chimeric antigen receptors have also highlighted their potential toxicities. The aim of this focused review was to describe the adverse events observed in these clinical trials and to link them to the complex biology of genetically targeted T cells. Finally, strategies to overcome these toxicities will be proposed and discussed, including the use of suicide genes and other innovative gene therapy strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available